Juan Camilo Arjona Ferreira - Nov 7, 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Stock symbol
OGN
Transactions as of
Nov 7, 2025
Transactions value $
-$15,480
Form type
4
Date filed
11/10/2025, 04:14 PM
Previous filing
Aug 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arjona Ferreira Juan Camilo Head of R&D & CMO C/O ORGANON &CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY /s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira 2025-11-10 0001714080

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +6.45K +26.02% $0.00 31.2K Nov 7, 2025 Direct
transaction OGN Common Stock Tax liability -$15.5K -2.31K -7.39% $6.71 28.9K Nov 7, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -6.45K -50% $0.00 6.45K Nov 7, 2025 Common Stock 6.45K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock.
F2 These restricted stock units vest and are distributed as shares of Organon common stock in three installments: 6,446 shares on November 7 2024; 6,446 shares on November 7, 2025; and 6,447 shares on November 7, 2026.